Tips for Compliance and Avoiding Government Investigations: Proper Disposal and Billing for Single-Use Drugs and Biological Waste and Guidelines for Managing Overfill
Continuing its aggressive efforts to combat fraud, waste and abuse in the health care system, the Federal government has focused on providers’ practices related to the disposing of and billing for single-use drugs and biological waste. Frier... Read More
As a result of the increased marketing by payors of over-the-counter (“OTC”) cards to plan members, pharmacists are being placed in jeopardy by patients who do not know, or appreciate, the legal complexities around proper use of these cards. The... Read More
All members of the health care industry have a legal and ethical duty to deal with the Federal health care programs (e.g., Medicare, Medicaid, and Tricare) with integrity. In keeping with this duty, practitioners are expected to employ measures to... Read More
Earlier this month, the Department of Health and Human Services Office of Inspector General (“OIG”) released a data brief that identified potential concerns of fraud, waste, or abuse in telehealth services delivered during the first year of the... Read More
A recent U.S. Supreme Court decision in the case of Ruan v. United States clarified the “intent element” in prosecutions of physicians for violations of the federal Controlled Substances Act (“CSA”) that are based on allegations... Read More
The Department of Justice ("DOJ") indicted a North Carolina physician assistant last month on criminal charges in a genetic testing scheme that resulted in the submission of more than $10 million in fraudulent claims to Medicare. The indictment... Read More
On July 14, 2022, the United States Department of Justice (DOJ) announced that OPKO Health, Inc. (“OPKO”) and its subsidiary, BioReference Health LLC (“BioReference”), agreed to pay $9.85 million to resolve claims under the Federal False... Read More
The Federal Anti-Kickback Statute (the “AKS”) prohibits the payment or receipt of remuneration to induce or reward referrals of items or services reimbursable by a federal health care program (including, but not limited to, Medicare and... Read More
Earlier this week, the U.S. Supreme Court ruled that to secure convictions under the federal Controlled Substances Act (“CSA”) for excessive prescribing of controlled substances, including opioids, prosecutors must prove beyond a reasonable... Read More
In the healthcare industry, Management Services Organizations (“MSOs”) have become an increasingly popular tool utilized by medical practices for a variety of purposes. MSOs are administrative and management entities that develop relationships... Read More
